The upcoming multi-center, multinational Phase 1 study will evaluate safety, tolerability, pharmacokinetics, and early signs of efficacy
Stivarga is the standard third-line treatment for metastatic colorectal cancer, gastrointestinal stromal tumors, and hepatocellular carcinoma
Vonoprozan is a novel potassium-competitive acid blocker used for the treatment of acid related disorders
It is estimated that one-third of our country’s population has some form of these disorders
Developed with Wondrlab India, the 10-episode series brings together healthcare experts, a cancer survivor, and filmmaker Amole Gupte to foster meaningful conversations
Exclusive licensing agreement combines Lonza’s dual-payload ADC technology with Antharis’ antibody engineering expertise
Approval is based on results from the phase 3 OASIS 4 clinical trial
Deal expands SPI Pharma’s manufacturing footprint in Germany, enhances pharmaceutical ingredient offerings, and reinforces focus on fast-growing digestive health market
Investigational once-weekly GLP-1 and amylin receptor agonist achieves up to 14.6% weight loss and significant blood sugar reductions
Novel fluorescent nanosensor enables real-time detection of indole-3-propionic acid (IPA), paving the way for faster gut health screening, point-of-care diagnostics, and wearable monitoring devices
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
